Tag: Atypical depression

Over 20 million adults experience major depressive episodes annually in the U.S.. For those who haven't found relief with common medications, **what does isocarboxazid treat**? Isocarboxazid is a potent monoamine oxidase inhibitor (MAOI) reserved for treatment-resistant depression and specific anxiety disorders.

First developed in the 1950s, MAO inhibitors are an older class of antidepressants that were largely sidelined by newer drugs due to safety concerns. However, the answer to the question "Are MAO inhibitors still prescribed?" is a definitive yes, though their use is now highly specialized and restricted to specific conditions.